KC
Therapeutic Areas
Allysta Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ALY688ER | Duchenne Muscular Dystrophy (DMD) | Phase 1 |
| ALY688 Ophthalmic Solution | Undisclosed Ophthalmic Condition(s) | Preclinical or Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| ALY688ER | Duchenne Muscular Dystrophy (DMD) | Phase 1 |
| ALY688 Ophthalmic Solution | Undisclosed Ophthalmic Condition(s) | Preclinical or Phase 1 |